These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2567101)
1. Suppression of prolactin release and mRNA accumulation by two novel dopamine agonist agents. Davis JR; Vidal ME; Wilson EM; Sheppard MC Acta Endocrinol (Copenh); 1989 May; 120(5):672-6. PubMed ID: 2567101 [TBL] [Abstract][Full Text] [Related]
2. Effects of two novel dopaminergic drugs, CV 205-502 and CQP 201-403, on prolactin and growth hormone secretion by human pituitary tumours in vitro. Venetikou MS; Burrin JM; Woods CA; Yeo TH; Brownell J; Adams EF Acta Endocrinol (Copenh); 1987 Oct; 116(2):287-92. PubMed ID: 3661066 [TBL] [Abstract][Full Text] [Related]
3. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion. Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995 [TBL] [Abstract][Full Text] [Related]
4. Stimulatory effects of quinpirole hydrochloride, D2-dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro. Tagawa R; Takahara J; Sato M; Niimi M; Murao K; Ishida T Life Sci; 1992; 51(10):727-32. PubMed ID: 1355255 [TBL] [Abstract][Full Text] [Related]
5. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491 [TBL] [Abstract][Full Text] [Related]
6. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin. Cronin MJ; Thorner MO J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209 [TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine. Hanna S; Shin SH Neuroendocrinology; 1992 May; 55(5):591-9. PubMed ID: 1316563 [TBL] [Abstract][Full Text] [Related]
11. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines. Markó M Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat. Trouillas J; Chevallier P; Claustrat B; Hooghe-Peters E; Dubray C; Rousset B; Girod C Endocrinology; 1994 Jan; 134(1):401-10. PubMed ID: 7903933 [TBL] [Abstract][Full Text] [Related]
13. Lisuride, a dopamine agonist, inhibits DNA synthesis in the pituitary gland. Burdman JA; Calabrese MT; Harcus CT; MacLeod RM Neuroendocrinology; 1982 Oct; 35(4):282-6. PubMed ID: 7145022 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing factor regulates growth hormone mRNA in primary cultures of rat pituitary cells. Gick GG; Zeytin FN; Brazeau P; Ling NC; Esch FS; Bancroft C Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1553-5. PubMed ID: 6424119 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of heat shock protein-70 expression in adrenal gland and aorta. Blake MJ; Buckley DJ; Buckley AR Endocrinology; 1993 Mar; 132(3):1063-70. PubMed ID: 8095012 [TBL] [Abstract][Full Text] [Related]
16. Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist properties. Gaillard RC; Brownell J Life Sci; 1988; 43(17):1355-62. PubMed ID: 2903425 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin partially impedes the stimulatory effects of thyrotrophin-releasing hormone and dibutyryl cyclic AMP on prolactin release: prolactin release through multiple routes. Shin SH; Heisler RL; Szabo MS J Endocrinol; 1991 Jul; 130(1):79-86. PubMed ID: 1679101 [TBL] [Abstract][Full Text] [Related]
18. [EGF binding site number of rat anterior pituitary is increased by chronic administration with dopaminergic agonist, CV 205-502]. Birman P; Bai-Grenier F; Joubert D C R Acad Sci III; 1991; 312(6):241-5. PubMed ID: 1675150 [TBL] [Abstract][Full Text] [Related]
19. Use of quin 2 to measure calcium concentrations in ovine anterior pituitary cells and the effects of quin 2 on secretion of growth hormone and prolactin. Hart GR; Ray KP; Wallis M FEBS Lett; 1986 Jul; 203(1):77-81. PubMed ID: 3087782 [TBL] [Abstract][Full Text] [Related]
20. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary. Pisarek H; Stepien H; Pawlikowski M Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]